207 related articles for article (PubMed ID: 28343311)
1. Mechanistic insight of platelet apoptosis leading to non-surgical bleeding among heart failure patients supported by continuous-flow left ventricular assist devices.
Mondal NK; Li T; Chen Z; Chen HH; Sorensen EN; Pham SM; Sobieski MA; Koenig SC; Slaughter MS; Griffith BP; Wu ZJ
Mol Cell Biochem; 2017 Sep; 433(1-2):125-137. PubMed ID: 28343311
[TBL] [Abstract][Full Text] [Related]
2. Intraplatelet reactive oxygen species, mitochondrial damage and platelet apoptosis augment non-surgical bleeding in heart failure patients supported by continuous-flow left ventricular assist device.
Mondal NK; Sorensen EN; Hiivala NJ; Feller ED; Pham SM; Griffith BP; Wu ZJ
Platelets; 2015; 26(6):536-44. PubMed ID: 25167344
[TBL] [Abstract][Full Text] [Related]
3. Oxidative stress induced modulation of platelet integrin α2bβ3 expression and shedding may predict the risk of major bleeding in heart failure patients supported by continuous flow left ventricular assist devices.
Mondal NK; Chen Z; Trivedi JR; Sorensen EN; Pham SM; Slaughter MS; Griffith BP; Wu ZJ
Thromb Res; 2017 Oct; 158():140-148. PubMed ID: 28915447
[TBL] [Abstract][Full Text] [Related]
4. Platelet glycoprotein Ibα ectodomain shedding and non-surgical bleeding in heart failure patients supported by continuous-flow left ventricular assist devices.
Hu J; Mondal NK; Sorensen EN; Cai L; Fang HB; Griffith BP; Wu ZJ
J Heart Lung Transplant; 2014 Jan; 33(1):71-9. PubMed ID: 24055626
[TBL] [Abstract][Full Text] [Related]
5. Association of Oxidative Stress and Platelet Receptor Glycoprotein GPIbα and GPVI Shedding During Nonsurgical Bleeding in Heart Failure Patients With Continuous-Flow Left Ventricular Assist Device Support.
Mondal NK; Chen Z; Trivedi JR; Sorensen EN; Pham SM; Slaughter MS; Griffith BP; Wu ZJ
ASAIO J; 2018; 64(4):462-471. PubMed ID: 28953486
[TBL] [Abstract][Full Text] [Related]
6. Decreased Platelet Specific Receptor Expression of P-Selectin and GPIIb/IIIa Predict Future Non-Surgical Bleeding in Patients after Left Ventricular Assist Device Implantation.
Klaeske K; Meyer AL; Saeed D; Eifert S; Jawad K; Sieg F; Haunschild J; Borger MA; Dieterlen MT
Int J Mol Sci; 2022 Sep; 23(18):. PubMed ID: 36142161
[TBL] [Abstract][Full Text] [Related]
7. Device-induced platelet dysfunction in patients after left ventricular assist device implantation.
Klaeske K; Dieterlen MT; Eifert S; Scholz U; Garbade J; Jawad K; Sieg F; Borger MA; Meyer AL
J Thromb Haemost; 2021 May; 19(5):1331-1341. PubMed ID: 33636040
[TBL] [Abstract][Full Text] [Related]
8. Systemic Inflammatory Response Syndrome in End-Stage Heart Failure Patients Following Continuous-Flow Left Ventricular Assist Device Implantation: Differences in Plasma Redox Status and Leukocyte Activation.
Mondal NK; Sorensen EN; Pham SM; Koenig SC; Griffith BP; Slaughter MS; Wu ZJ
Artif Organs; 2016 May; 40(5):434-43. PubMed ID: 26416627
[TBL] [Abstract][Full Text] [Related]
9. The Glycoprotein (GP)Ib-IX-V Complex on Platelets: GPIbα Protein Expression Is Reduced in HeartMate 3 Patients with Bleeding Complications within the First 3 Months.
Klaeske K; Brade A; Eifert S; Jawad K; Saeed D; Haunschild J; Sieg F; Borger MA; Dieterlen MT
Int J Mol Sci; 2023 Mar; 24(6):. PubMed ID: 36982712
[TBL] [Abstract][Full Text] [Related]
10. Comparison of intraplatelet reactive oxygen species, mitochondrial damage, and platelet apoptosis after implantation of three continuous flow left ventricular assist devices: HeartMate II, Jarvik 2000, and HeartWare.
Mondal NK; Sorensen EN; Feller ED; Pham SM; Griffith BP; Wu ZJ
ASAIO J; 2015; 61(3):244-52. PubMed ID: 25757140
[TBL] [Abstract][Full Text] [Related]
11. Systemic Inflammatory Response Syndrome After Contentious-Flow Left Ventricular Assist Device Implantation and Change in Platelet Mitochondrial Membrane Potential.
Mondal NK; Sorensen EN; Feller ED; Pham SM; Griffith BP; Wu ZJ
J Card Fail; 2015 Jul; 21(7):564-71. PubMed ID: 25921521
[TBL] [Abstract][Full Text] [Related]
12. Acquired platelet defects are responsible for nonsurgical bleeding in left ventricular assist device recipients.
Arias K; Sun W; Wang S; Sorensen EN; Feller E; Kaczorowski D; Griffith B; Wu ZJ
Artif Organs; 2022 Nov; 46(11):2244-2256. PubMed ID: 35596611
[TBL] [Abstract][Full Text] [Related]
13. Increased cyclic guanosine monophosphate levels and continuous-flow left-ventricular assist devices: Implications for gastrointestinal bleeding.
Grosman-Rimon L; Tumiati LC; Fuks A; Jacobs I; Lalonde SD; Cherney DZ; Rao V
J Thorac Cardiovasc Surg; 2016 Jan; 151(1):219-27. PubMed ID: 26515873
[TBL] [Abstract][Full Text] [Related]
14. Infection, Oxidative Stress, and Changes in Circulating Regulatory T Cells of Heart Failure Patients Supported by Continuous-Flow Ventricular Assist Devices.
Mondal NK; Sobieski MA; Pham SM; Griffith BP; Koenig SC; Slaughter MS; Wu ZJ
ASAIO J; 2017; 63(2):128-133. PubMed ID: 27922883
[TBL] [Abstract][Full Text] [Related]
15. Oxidative stress, DNA damage and repair in heart failure patients after implantation of continuous flow left ventricular assist devices.
Mondal NK; Sorensen E; Hiivala N; Feller E; Griffith B; Wu ZJ
Int J Med Sci; 2013; 10(7):883-93. PubMed ID: 23781134
[TBL] [Abstract][Full Text] [Related]
16. Tumor necrosis factor-α levels and non-surgical bleeding in continuous-flow left ventricular assist devices.
Tabit CE; Coplan MJ; Chen P; Jeevanandam V; Uriel N; Liao JK
J Heart Lung Transplant; 2018 Jan; 37(1):107-115. PubMed ID: 28651907
[TBL] [Abstract][Full Text] [Related]
17. Platelet activation is a preoperative risk factor for the development of thromboembolic complications in patients with continuous-flow left ventricular assist device.
Consolo F; Sferrazza G; Motolone G; Contri R; Valerio L; Lembo R; Pozzi L; Della Valle P; De Bonis M; Zangrillo A; Fiore GB; Redaelli A; Slepian MJ; Pappalardo F
Eur J Heart Fail; 2018 Apr; 20(4):792-800. PubMed ID: 29282819
[TBL] [Abstract][Full Text] [Related]
18. Platelet Secretion Defects and Acquired von Willebrand Syndrome in Patients With Ventricular Assist Devices.
Geisen U; Brehm K; Trummer G; Berchtold-Herz M; Heilmann C; Beyersdorf F; Schelling J; Schlagenhauf A; Zieger B
J Am Heart Assoc; 2018 Jan; 7(2):. PubMed ID: 29331958
[TBL] [Abstract][Full Text] [Related]
19. Development of acquired von Willebrand syndrome during short-term micro axial pump support: implications for bleeding in a patient bridged to a long-term continuous-flow left ventricular assist device.
Davis ME; Haglund NA; Tricarico NM; Keebler ME; Maltais S
ASAIO J; 2014; 60(3):355-7. PubMed ID: 24614358
[TBL] [Abstract][Full Text] [Related]
20. Inhibition of ADAMTS-13 by Doxycycline Reduces von Willebrand Factor Degradation During Supraphysiological Shear Stress: Therapeutic Implications for Left Ventricular Assist Device-Associated Bleeding.
Bartoli CR; Kang J; Restle DJ; Zhang DM; Shabahang C; Acker MA; Atluri P
JACC Heart Fail; 2015 Nov; 3(11):860-9. PubMed ID: 26454844
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
